ProfileGDS5678 / 1432131_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 6% 6% 6% 6% 6% 6% 6% 6% 6% 6% 6% 6% 6% 6% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.133656
GSM967853U87-EV human glioblastoma xenograft - Control 22.112066
GSM967854U87-EV human glioblastoma xenograft - Control 32.114286
GSM967855U87-EV human glioblastoma xenograft - Control 42.060916
GSM967856U87-EV human glioblastoma xenograft - Control 52.06756
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.163726
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.141226
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.089076
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.079446
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.099626
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.094766
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.084276
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.107736
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.099356